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1682-606X/Copyright ª 2014, TaiwanSummary Benign fibrous histiocytoma is one of the most common mesenchymal neoplasms of
the skin, but it rarely occurs in deep soft tissues. Deep fibrous histiocytoma commonly occurs
in the lower limbs or the head and neck region. We report an extremely rare case of deep
fibrous histiocytoma arising from the sigmoid mesocolon. A 63-year-old woman initially pre-
sented with lower abdominal pain. An image study showed a huge heterogeneous pelvic mass
with bleeding. The patient was treated successfully by surgery. We review the literature and
discuss the clinical presentation, diagnosis, and management of deep fibrous histiocytoma.
Copyright ª 2014, Taiwan Surgical Association. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
Benign fibrous histiocytoma (FH) is a tumor composed of a
mixture of fibroblastic and histiocystic cells.1 FH is one of
the most common mesenchymal neoplasms of the skin, but
rarely occurs in deep soft tissues. Deep benign FH is an
uncommon and poorly recognized clinical subtype that
arises in subcutaneous or deep soft tissue.2 Deep benign FH
most commonly occurs in the lower limbs or the head and
neck region. We report an extremely rare case of deep
benign FH arising from the sigmoid mesocolon.clare no conflicts of interest.
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Surgical Association. Published by2. Case Report
A 63-year-old woman, who reached menopause about 7e8
years earlier, presented to our emergency department
because of diffuse lower abdominal pain with sudden onset
in the morning, associated with mild nausea. According to
the patient, she had had frequent attacks of abdominal
fullness, especially after meals. However, she denied body
weight change, poor appetite, bowel habit change, con-
stipation, or urinary frequency. At our emergency depart-
ment, vital signs were found to be relatively stable, but
physical examination revealed a huge lower abdominal
mass with diffuse tenderness and equivocal peritoneal
signs. An abdominal computed tomography scan showed a
huge heterogeneous pelvic mass with bleeding (Fig. 1).
Gynecologic sonography showed mild ascites and one het-
erogeneous pelvic tumor of about 17 cm  14 cm  9 cm;
ovarian tumor could not be ruled out.Elsevier Taiwan LLC. All rights reserved.
Figure 1 Contrast-enhanced abdominal computed tomogra-
phy: a heterogeneous tumor, 18 cm  15 cm  10 cm in size,
arising from the sigmoid mesocolon.
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found tumor rupture with bleeding when the peritoneal
cavity was opened. We observed intraoperatively that the
tumor was deep-seated and arising from the sigmoid mes-
ocolon. The lesion was totally excised with partial sigmoi-
dectomy (Fig. 2). There was normal atrophied uterus and
ovaries. The patient recovered uneventfully and was dis-
charged on the 7th day after the operation.
The surgical specimen was a well-circumscribed
neoplasm, which had a storiform growth pattern andFigure 2 Grossly smooth, well-circumscribed, encapsulated
mass lesion, about 20 cm in diameter.relatively uniform cytomorphology, consisting of spindle-
shaped or more ovoid cells with a limited amount of pale
cytoplasm. There were focally admixed foamy histocytes
(Fig. 3). Immunohistochemistry and special stains of the
tumor cells were diffusely positive for CD34, whereas alpha
smooth muscle actin, S-100 protein, keratins, and other
special stains were negative. Gastrointestinal stromal
tumor, endometrial stromal sarcoma, follicular dendritic
cell sarcoma, and melanoma were therefore not likely. The
appearance and immunophenotype fitted well with deep
benign FH. Based on the surgical and histological findings,
deep FH with bleeding was diagnosed. The patient was free
of locoregional disease after 12 months of follow-up.3. Discussion
Benign FH is usually of two types: cutaneous type and that
involving deep soft tissues. Histologically, deep FH has
many features in common with cutaneous cellular FH,
including a storiform and/or short fascicular growth
pattern, similar cytologic features with frequently limited
or absent polymorphism, and increased cellularity.3 Deep
benign FH is an under-recognized neoplasm that most
commonly arises in the subcutaneous tissue of the ex-
tremities, but may occur at any soft tissue site. The most
important diagnostic distinction is the separation of this
tumor from the malignant type. Histopathologically, this
tumor is a neoplasm of a biphasic cell population of his-
tiocytes and fibroblasts.3 Diagnosis of benign FH is often
difficult and usually based on immunohistochemistry. The
immunohistochemistry can help in making a differential
diagnosis of the soft tissue tumor. Negativity for smooth
muscle actin and S-100 can differentiate the lesion from
leiomyosarcoma and neurogenic tumors.4 Gastrointestinal
stromal tumors are one of the most common mesenchymal
tumors of the gastrointestinal tract. Most gastrointestinal
stromal tumors are c-kit positive (other possible markers
include CD34, DOG-1, and desmin). In our case, the
immunohistochemistry was not correlated with this crite-
rion. Negativity for CD10, CD56, AE1/3, EMA, calretinin,
alpha-inhibin, and D2-40 ruled out gynecologic lesions andFigure 3 Storiform architecture with staghorn vessels
(hematoxylin and eosin, 100).
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dritic cell sarcoma. MDM2/CDK4 is used for liposarcomas.
Malignant FH is composed of malignant pleomorphic
sarcomatous cells, bizarre giant cells, and frequent mitotic
figures.5 The difference between benign and malignant FH
is usually obvious, because the latter is a pleomorphic,
deep-seated tumor with numerous typical and atypical
mitotic figures.6
Gleason and Fletcher2 reviewed the clinicopathologic
features of 69 cases of deep benign FH. The most common
anatomic locations were the extremities (58%). Lesions
arising in visceral soft tissue were rare. The local recur-
rence rate of deep benign FH was 22%, which is significantly
higher than that of conventional cutaneous FH. Deep FH
seems to have an increased risk of local recurrence as
compared with conventional FH and also has a very low
(and seemingly unpredictable) risk of distant metastasis.
In conclusion, we report a rare case of deep FH arising
from the sigmoid mesocolon. To the best of our knowledge,
no tumor bleeding case has been reported. Although rare,
benign FH must be considered in the differential diagnosis
of pelvic tumors. The prognosis of benign FH is excellent if
complete excision is performed. Currently, radiation ther-
apy and chemotherapy have no role in the management of
benign FH. Our patient had complete excision of the tumor
with clear margins, without any morbidity. Regular follow-up was suggested because of the risk of local recurrence
and distant metastasis.References
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